NCT06992596RECRUITINGanonymous

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Sponsor

Source record

Neuralink Corp

Phase

Source record

Modality

AI-normalized

medical device

Target

AI-normalized

N1 Implant, R1 Robot

Indication / condition

AI-normalized

Tetraplegia/Tetraparesis

Intervention

Source record

N1 Implant, R1 Robot

Source & freshness

Source record

NCT ID

NCT06992596

Original source

ClinicalTrials.gov

Source last updated

Jun 05, 2025

Ingested at

Jun 16, 2026

Internal sync

Jun 16, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT06992596

Title

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Sponsor

Neuralink Corp

Status

RECRUITING

Phase

Condition raw

Tetraplegia/Tetraparesis, Quadriplegia, Quadriplegia/Tetraplegia, Cervical Spinal Cord Injury, Amyotrophic Lateral Sclerosis (ALS), Spinal Cord Injury (Quadraplegia), Spinal Cord Injury, Motor Neuron Disease, Brain Stem Stroke

Condition normalized

Modality raw

medical device

Modality normalized

medical device

Target raw

N1 Implant, R1 Robot

Target normalized

N1 Implant, R1 Robot

Interventions

N1 Implant, R1 Robot

Public preview

Source record

The N1 Implant is a wireless, rechargeable device mounted on the skull, connected to electrode threads that are inserted into the brain by the R1 Robot, which is a robotic device specifically designed for this procedure.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 17, 2026

NCT ID

NCT06992596

Status

RECRUITING

Phase

Sponsor

Neuralink Corp

Executive brief

Investment-Ready Snapshot

The UAE-PRIME Study is a feasibility study designed to assess the initial clinical safety and functionality of the Neuralink N1 Implant and R1 Robot. This study involves participants who have tetraparesis, tetraplegia, or a diagnosis that may lead to these conditions. The N1 Implant is a wireless, rechargeable device mounted on the skull, connected to electrode threads that are inserted into the brain by the R1 Robot, which is a robotic device specifically designed for this procedure.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedJun 05, 2025

Internal syncJun 16, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT06992596

Indication

Tetraplegia/Tetraparesis

Modality

medical device

Target

N1 Implant, R1 Robot

Intervention

N1 Implant, R1 Robot

Source record